Target-Activated prodrugs (TAPs) for the autoregulated inhibition of MMP12
We describe a prodrug concept in which the target enzyme MMP12 produces its own inhibitor in a two-step activation procedure. By using an MMP12-specific peptide sequence and a known sulfonamide drug integrated in the backbone, the active inhibitor is released upon enzyme cleavage. In in vitro experi...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
20 July 2012
|
| In: |
ACS medicinal chemistry letters
Year: 2012, Volume: 3, Issue: 8, Pages: 653-657 |
| ISSN: | 1948-5875 |
| DOI: | 10.1021/ml3001193 |
| Online Access: | Verlag, Volltext: http://dx.doi.org/10.1021/ml3001193 Verlag, Volltext: https://doi.org/10.1021/ml3001193 
|
| Author Notes: | Amanda Cobos-Correa, Frank Stein, Carsten Schultz |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1580013929 | ||
| 003 | DE-627 | ||
| 005 | 20230427065639.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 180814s2012 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1021/ml3001193 |2 doi | |
| 035 | |a (DE-627)1580013929 | ||
| 035 | |a (DE-576)510013929 | ||
| 035 | |a (DE-599)BSZ510013929 | ||
| 035 | |a (OCoLC)1341016910 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Cobos-Correa, Amanda |e VerfasserIn |0 (DE-588)141335041 |0 (DE-627)703950053 |0 (DE-576)323376401 |4 aut | |
| 245 | 1 | 0 | |a Target-Activated prodrugs (TAPs) for the autoregulated inhibition of MMP12 |c Amanda Cobos-Correa, Frank Stein, Carsten Schultz |
| 264 | 1 | |c 20 July 2012 | |
| 300 | |a 5 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Published online 20 July 2012 | ||
| 500 | |a Gesehen am 14.08.2018 | ||
| 520 | |a We describe a prodrug concept in which the target enzyme MMP12 produces its own inhibitor in a two-step activation procedure. By using an MMP12-specific peptide sequence and a known sulfonamide drug integrated in the backbone, the active inhibitor is released upon enzyme cleavage. In in vitro experiments, we present proof of concept that the activation proceeds with useful kinetics. The approach is highly selective over the closely related MMP8. If applied in vivo in the future, these prodrugs might release the active entity in a highly specific manner only at such sites where enzyme activity resides. | ||
| 700 | 1 | |a Stein, Frank |e VerfasserIn |0 (DE-588)1076138101 |0 (DE-627)834464551 |0 (DE-576)444985433 |4 aut | |
| 700 | 1 | |a Schultz, Carsten |e VerfasserIn |0 (DE-588)1139307444 |0 (DE-627)897060490 |0 (DE-576)493231013 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t ACS medicinal chemistry letters |d Washington, DC : ACS, 2010 |g 3(2012), 8, Seite 653-657 |h Online-Ressource |w (DE-627)61638596X |w (DE-600)2532386-6 |w (DE-576)318518287 |x 1948-5875 |7 nnas |a Target-Activated prodrugs (TAPs) for the autoregulated inhibition of MMP12 |
| 773 | 1 | 8 | |g volume:3 |g year:2012 |g number:8 |g pages:653-657 |g extent:5 |a Target-Activated prodrugs (TAPs) for the autoregulated inhibition of MMP12 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1021/ml3001193 |x Verlag |x Resolving-System |3 Volltext |
| 856 | 4 | 0 | |u https://doi.org/10.1021/ml3001193 |x Verlag |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20180814 | ||
| 993 | |a Article | ||
| 994 | |a 2012 | ||
| 998 | |g 1139307444 |a Schultz, Carsten |m 1139307444:Schultz, Carsten |d 910000 |e 910000PS1139307444 |k 0/910000/ |p 3 |y j | ||
| 998 | |g 141335041 |a Cobos-Correa, Amanda |m 141335041:Cobos-Correa, Amanda |d 910000 |e 910000PC141335041 |k 0/910000/ |p 1 |x j | ||
| 999 | |a KXP-PPN1580013929 |e 3022316453 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"id":{"eki":["1580013929"],"doi":["10.1021/ml3001193"]},"origin":[{"dateIssuedDisp":"20 July 2012","dateIssuedKey":"2012"}],"relHost":[{"pubHistory":["1.2010 -"],"part":{"extent":"5","volume":"3","pages":"653-657","year":"2012","issue":"8","text":"3(2012), 8, Seite 653-657"},"id":{"zdb":["2532386-6"],"eki":["61638596X"],"issn":["1948-5875"]},"type":{"bibl":"periodical","media":"Online-Ressource"},"origin":[{"dateIssuedDisp":"2010-","publisherPlace":"Washington, DC","dateIssuedKey":"2010","publisher":"ACS"}],"note":["Gesehen am 05.12.2018"],"recId":"61638596X","title":[{"title":"ACS medicinal chemistry letters","title_sort":"ACS medicinal chemistry letters"}],"language":["eng"],"physDesc":[{"extent":"Online-Ressource"}],"name":{"displayForm":["American Chemical Society"]},"disp":"Target-Activated prodrugs (TAPs) for the autoregulated inhibition of MMP12ACS medicinal chemistry letters","titleAlt":[{"title":"JMCLett"}]}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"recId":"1580013929","note":["Published online 20 July 2012","Gesehen am 14.08.2018"],"language":["eng"],"title":[{"title_sort":"Target-Activated prodrugs (TAPs) for the autoregulated inhibition of MMP12","title":"Target-Activated prodrugs (TAPs) for the autoregulated inhibition of MMP12"}],"physDesc":[{"extent":"5 S."}],"person":[{"family":"Cobos-Correa","given":"Amanda","display":"Cobos-Correa, Amanda","role":"aut","roleDisplay":"VerfasserIn"},{"display":"Stein, Frank","given":"Frank","family":"Stein","role":"aut","roleDisplay":"VerfasserIn"},{"roleDisplay":"VerfasserIn","role":"aut","display":"Schultz, Carsten","given":"Carsten","family":"Schultz"}],"name":{"displayForm":["Amanda Cobos-Correa, Frank Stein, Carsten Schultz"]}} | ||
| SRT | |a COBOSCORRETARGETACTI2020 | ||